Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Impact of Anti-Microbial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

Fumiya Wada, Yasuyuki Arai, MDPhD, Junya Kanda, MD PhD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Kondo Takaori, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139100

Published: 2020

Journal Articles

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Tomoki Iemura, MD, Yasuyuki Arai, MD PhD, Junya Kanda, MD, Toshio Kitawaki, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 3267.

https://doi.org/10.1182/blood-2019-123073

Published: 2019

Journal Articles

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Ryo Ishino, Yumi Kawase, MD, Toshio Kitawaki, MD PhD, Naoshi Sugimoto, MD PhD, Maki Oku, MD, Shumpei Uchida, MD, Osamu Imataki, MD PhD, Akihito Matsuoka, MD PhD, Teruhisa Taoka, MD PhD, Kimihiro Kawakami, MD PhD, Tomoki Todo, MD PhD, Akifumi Takaori-Kondo, MD PhD, Norimitsu Kadowaki, MD PhD

Blood (2019) 134 (Supplement_1): 3242.

https://doi.org/10.1182/blood-2019-127754

Published: 2019

Journal Articles

Expansion of Dysfunctional CD56-Negative NK Cells Is a Hallmark of NK Cell Activation in Ph + Leukemia Patients Treated with Dasatinib

Ken-ichi Ishiyama, MD, Toshio Kitawaki, MD PhD, Naoshi Sugimoto, MD PhD, Akifumi Takaori-Kondo, MD PhD, Norimitsu Kadowaki, MD PhD

Blood (2016) 128 (22): 1904.

https://doi.org/10.1182/blood.V128.22.1904.1904

Published: 2016

Journal Articles

Regeneration of Tumor Antigen Specific CTLs Utilizing iPSC Technology for Off-the-Shelf Immunotherapy

Takuya Maeda, MD, Seiji Nagano, MD, Kyoko Masuda, PhD, Toshio Kitawaki, MD PhD, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Norimitsu Kadowaki, MD PhD, Akifumi Kondo Takaori, MD PhD, Hiroshi Kawamoto, MD PhD

Blood (2016) 128 (22): 4554.

https://doi.org/10.1182/blood.V128.22.4554.4554

Published: 2016

Journal Articles

Dasatinib Expands Pre-Existing, CMV-Associated, Highly Differentiated NK Cells in Ph + Leukemia

Ken-ichi Ishiyama, MD, Toshio Kitawaki, MD, PhD, Akifumi Takaori, MD, PhD, Norimitsu Kadowaki, MD PhD

Blood (2014) 124 (21): 3149.

https://doi.org/10.1182/blood.V124.21.3149.3149

Published: 2014

Journal Articles

Expression of Tim-1 and Its Pathogenetic Role in Primary CNS Lymphoma

Momoko Nishikori, MD, PhD, Wataru Kishimoto, MD, Hiroshi Arima, MD, Kotaro Shirakawa, MD, PhD, Toshio Kitawaki, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2014) 124 (21): 2961.

https://doi.org/10.1182/blood.V124.21.2961.2961

Published: 2014

Journal Articles

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

June Takeda, MD, Hiroshi Kawabata, MD, PhD, Kazunari Aoki, MD, Shuichi Shiga, S.H., Masahiro Kawahara, MD PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiyuki Kitano, MD, Noboru Yonetani, MD, Sumie Tabata, MD, PhD, Nobuhiro Hiramoto, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, Norimitsu Kadowaki, MD PhD, Akifumi Takaori, MD, PhD

Blood (2014) 124 (21): 1907.

https://doi.org/10.1182/blood.V124.21.1907.1907

Published: 2014

Journal Articles

Idiopathic CD4 Lymphocytopenia Due to Loss of Heterozygosity of the Mutant CD2 Gene

Masaharu Tashima, MD, Momoko Nishikori, MD, PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD, PhD, Taisuke Izumi, PhD, Yayoi Fujiwara, MD, Minako Mori, MD, Kaori Kihara, MD, Katsuyuki Ohmori, PhD, Tadakazu Kondo, MD, PhD, Takayuki Ishikawa, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2010) 116 (21): 2774.

https://doi.org/10.1182/blood.V116.21.2774.2774

Published: 2010

Journal Articles

Protein Kinase Inhibitor Dasatinib Potently Suppresses Immunostimulatory Activity of Human Plasmacytoid Dendritic Cells

Haruyuki Fujita, MD, Toshio Kitawaki, MD, PhD, Takashi Uchiyama, MD, PhD, Akifumi Takaori-Kondo, MD, PhD, Norimitsu Kadowaki, MD, PhD

Blood (2010) 116 (21): 3896.

https://doi.org/10.1182/blood.V116.21.3896.3896

Published: 2010

NARROW

The Impact of Anti-Microbial Drug-Drug Interactions on Acute Kidney Injury after Allogeneic Hematopoietic Cell Transplantation

Impact of HLA Class I Allele Mismatch on Viral Infection within 100 Days after Cord Blood Transplantation

Oncolytic Virus Therapy with HSV-1 for Hematologic Malignancies

Expansion of Dysfunctional CD56-Negative NK Cells Is a Hallmark of NK Cell Activation in Ph + Leukemia Patients Treated with Dasatinib

Regeneration of Tumor Antigen Specific CTLs Utilizing iPSC Technology for Off-the-Shelf Immunotherapy

Dasatinib Expands Pre-Existing, CMV-Associated, Highly Differentiated NK Cells in Ph + Leukemia

Expression of Tim-1 and Its Pathogenetic Role in Primary CNS Lymphoma

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

Idiopathic CD4 Lymphocytopenia Due to Loss of Heterozygosity of the Mutant CD2 Gene

Protein Kinase Inhibitor Dasatinib Potently Suppresses Immunostimulatory Activity of Human Plasmacytoid Dendritic Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only